---
title: "Kingmed Diagnostics: Third quarter net profit of 5.1973 million yuan, a year-on-year increase of 24.08%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263270120.md"
description: "Kingmed Diagnostics announced that its revenue for the third quarter was 1.541 billion yuan, a year-on-year decrease of 11.32%; net profit was 5.1973 million yuan, a year-on-year increase of 24.08%. Revenue for the first three quarters was 4.538 billion yuan, a year-on-year decrease of 19.23%; net profit recorded a loss of 79.6095 million yuan, a year-on-year decrease of 184.84%"
datetime: "2025-10-29T11:03:14.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263270120.md)
  - [en](https://longbridge.com/en/news/263270120.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263270120.md)
---

# Kingmed Diagnostics: Third quarter net profit of 5.1973 million yuan, a year-on-year increase of 24.08%

Kingmed Diagnostics announced that its revenue for the third quarter was 1.541 billion yuan, a year-on-year decrease of 11.32%; net profit was 5.1973 million yuan, a year-on-year increase of 24.08%. Revenue for the first three quarters was 4.538 billion yuan, a year-on-year decrease of 19.23%; net profit loss was 79.6095 million yuan, a year-on-year decrease of 184.84%

### Related Stocks

- [603882.CN](https://longbridge.com/en/quote/603882.CN.md)

## Related News & Research

- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [Europe-China spacecraft launches to study Earth's 'invisible armour'](https://longbridge.com/en/news/286881963.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [09:09 ETPacific Mind Health Releases Free Guide to Help People Start Conversations About Mental Health](https://longbridge.com/en/news/287072254.md)
- [New York Governor Signs Bills To Preserve Mandatory Vaccines](https://longbridge.com/en/news/286947583.md)